BC up +1.54% percent right now. $BC High is at 48.42 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
BC up +1.54% percent right now. $BC High is at 48.42 and the Low 47.39 with current volume of 358,542.

Recent News posted below.

BC Brunswick Corp Recent Headline News

Earnings Look Back: Brunswick Is Up 5.9% Since Reporting Quarterly Results 2 Weeks Ago (BC)
Comtex SmarTrend(R) - 1 hr ago
Two weeks ago on October 23rd, 2014 Brunswick (NYSE:BC) reported earnings and analysts, on average, expected earnings of $0.58 on sales of $915.8 million. Brunswick actually reported earnings of $0.63 per share on sales of $932.1 million, beating EPS estimates by $0.05 and beating revenue estimates by $16.3 million. Since the company's report, shares of Brunswick have risen from $44.89 to $47.52, representing a gain of 5.9% in the past 18 days.
BC: 48.55 (+1.03)

Mercury Racing Unveils Concept Small Block Four-Valve Engine at SEMA
M2 - Wed Nov 05, 4:08AM CST
FOND DU LAC, Wis. - Mercury Racing unveiled a concept small block four-valve automotive crate engine today at the Specialty Equipment Market Association (SEMA) show in Las Vegas. SEMA consists of a diverse group of manufacturers, distributors, retailers, publishing companies, auto restorers, street-rod builders, restylers, car clubs, race teams and more.
BC: 48.55 (+1.03), GM: 31.06 (-0.53)

Shares of BC Up 12.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Nov 04, 9:26AM CST
SmarTrend identified an Uptrend for Brunswick (NYSE:BC) on October 20th, 2014 at $41.81. In approximately 2 weeks, Brunswick has returned 12.51% as of today's recent price of $47.04.
BC: 48.55 (+1.03)

Brunswick
at Investor's Business Daily - Thu Oct 23, 6:01PM CDT
Brunswick (BC), a boat and sporting goods company, said that its Q3 EPS rose 6.8% to 63 cents, beating views by 5 cents. Revenue grew 4.4% to $932 mil, topping views for $916 mil. Shares rose 3.5% to 44.89.
BC: 48.55 (+1.03)

Brunswick's (BC) CEO Dustan McCoy on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 3:40PM CDT

BC: 48.55 (+1.03)

Brunswick (BC) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 23, 9:55AM CDT

BC: 48.55 (+1.03)

Brunswick tops Street 3Q forecasts
Automated Insights - Thu Oct 23, 9:10AM CDT
LAKE FOREST, Ill. (AP) _ Brunswick Corp. (BC) on Thursday reported earnings of $104.4 million in its third quarter.
BC: 48.55 (+1.03)

Brunswick beats by $0.05, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 7:21AM CDT

BC: 48.55 (+1.03)

Brunswick Corporation : Brunswick Reports Third Quarter 2014 Earnings
Thomson Reuters ONE - Thu Oct 23, 6:36AM CDT
LAKE FOREST, Ill., Oct. 23, 2014 - Brunswick Corporation (NYSE: BC) today has released its third quarter 2014 financial results. A complete and full-text financial results press release is available on the Company's website at www.brunswick.com/investors. The results will also be available on the SEC's website with the Form 8-K filing of the release at http://goo.gl/wJQN1.
BC: 48.55 (+1.03)

Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Oct 22, 4:30PM CDT

CRS: 51.21 (-1.66), CAM: 58.49 (-0.75), LAZ: 49.28 (-0.02), JAH: 66.75 (+0.52), ASPS: 69.42 (-0.63), BBW: 17.92 (+0.14), LO: 62.18 (+0.10), CAB: 50.62 (+1.16), CFX: 54.41 (-0.35), FAF: 30.33 (+0.03), KKR: 21.87 (+0.48), AEP: 58.31 (-0.01), DNKN: 47.32 (+0.28), DO: 37.13 (-1.61), JAKK: 6.54 (+0.03), AAL: 43.72 (+0.52), DAN: 20.21 (-0.16), CAT: 102.12 (+0.36), CSH: 49.54 (+0.39), LSTR: 77.29 (+0.56), BHE: 24.00 (unch), ARG: 113.68 (-0.56), AVT: 43.51 (-0.17), ALV: 94.74 (+1.23), ALK: 56.23 (+1.09), BKU: 30.64 (+0.36), CELG: 107.95 (+1.50), CWEI: 84.45 (-4.45), BCC: 36.49 (-0.94), HERO: 1.57 (-0.17), AB: 26.50 (+0.25), DGX: 62.62 (+0.93), ALXN: 195.25 (+1.44), CHKP: 74.71 (+0.04), MDP: 50.55 (+0.35), ACAT: 33.99 (+0.13), GRUB: 33.59 (+0.34), JBLU: 13.08 (+0.52), CLI: 19.62 (-0.22), CVE: 24.74 (-0.51), CCE: 42.48 (-0.24), LUV: 38.98 (+0.74), DPS: 70.32 (+0.37), IVC: 16.13 (+0.33), GMT: 65.17 (+0.06), BC: 48.55 (+1.03), JNS: 15.18 (-0.13), DLX: 60.66 (-0.01), CMS: 33.14 (+0.23), LTM: 56.66 (+0.82), CS: 25.98 (+0.14), LLY: 68.34 (+1.74), BMS: 39.22 (+0.01), IMAX: 29.00 (+0.15), EQT: 95.50 (-3.14), GPI: 86.14 (-1.14), EQM: 87.38 (-1.27), GM: 31.06 (-0.53), CRI: 77.70 (-1.46), CMCSA: 52.47 (-2.68), HUB.B: 111.94 (+0.44)

Brunswick Corporation : Brunswick Names Dekker Vice President, General Counsel and Secretary
Thomson Reuters ONE - Wed Oct 22, 3:46PM CDT
LAKE FOREST, Ill., Oct. 22, 2014 - Brunswick Corporation (NYSE:BC) today announced that Christopher F. Dekker, 46, has been named vice president, general counsel and secretary. He reports to Chairman and Chief Executive Officer Dustan E. McCoy.
BC: 48.55 (+1.03)

A Lot Of Potential Upside Remains In Small-Cap Stocks
Hawkinvest - at Seeking Alpha - Wed Oct 22, 3:08PM CDT

MDR: 3.95 (-0.07), BC: 48.55 (+1.03), CNO: 18.06 (-0.06), JGW: 11.40 (+0.04)

Life Fitness Names the 2014 Top Personal Trainer
Marketwired - Wed Oct 22, 10:01AM CDT
The top 10 personal trainers in the world descended on DavidBartonGym in New York City on Oct. 17 to demonstrate their elite training skills and passion for fitness at the Life Fitness Personal Trainers to Watch competition -- and one trainer emerged the winner. Today, Life Fitness announces that Cristiano Arthur S. Parente, 38, of Sao Paulo, Brazil, has won the Life Fitness 2014 Personal Trainers to Watch competition.
BC: 48.55 (+1.03)

Brunswick Corporation : Brunswick Corporation Declares Dividend
Thomson Reuters ONE - Wed Oct 22, 9:01AM CDT
LAKE FOREST, Ill., Oct. 22, 2014 - The board of directors of Brunswick Corporation (NYSE: BC) today declared a quarterly dividend on the Company's common stock of $0.125 per share payable Dec. 15, 2014, to shareholders of record on Nov. 25, 2014.
BC: 48.55 (+1.03)

Brunswick Corporation : Brunswick Announces Stock Repurchase Authorization
Thomson Reuters ONE - Wed Oct 22, 8:58AM CDT
LAKE FOREST, Ill., Oct. 22, 2014 - Brunswick Corporation (NYSE: BC) today announced that its board of directors has authorized the discretionary repurchase of up to $200 million of the Company's outstanding common stock. Share repurchases will be systematically completed in the open market or through privately negotiated transactions over approximately a two-year period.
BC: 48.55 (+1.03)

Brunswick Corporation : Crestliner Receives Seventh Consecutive NMMA CSI Award For Excellence In Customer Satisfaction For Aluminum Boats
Thomson Reuters ONE - Tue Oct 21, 9:21AM CDT
OTSEGO, Minn., Oct. 21, 2014 - For the seventh year in a row, the National Marine Manufacturers Association (NMMA) has awarded Crestliner with a Marine Industry Customer Satisfaction Index (CSI) award. Crestliner's seventh CSI award recognizes the brand's excellence in customer satisfaction, as well as every Crestliner's built-to-outlast construction. Highlighting Crestliner's quality as appreciated by Crestliner customers, this award honors boatbuilders whose customer-satisfaction scores, based on independent surveys of all their new boat customers, are among the best in the industry.
BC: 48.55 (+1.03)

ANSS, BIP, STT, NPBC, BC, BEAV Expected To Be Up Before Next Earnings Releases
M2 - Wed Oct 08, 3:18AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 quarterly, 6 quarterly and November earnings reports. ANSYS Inc (NASDAQ:ANSS), Brookfield Infrastructure Partners LP (NYSE:BIP), State Street Corp (NYSE:STT), National Penn Bancshares Inc (NASDAQ:NPBC), Brunswick Corp (NYSE:BC), BE Aerospace Inc (NASDAQ:BEAV) are all expected to be Up Before their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Up Before earnings are released Thursday:
NPBC: 10.32 (+0.06), STT: 78.01 (+0.20), BC: 48.55 (+1.03), BIP: 41.00 (+0.59), ANSS: 79.21 (-0.34), BEAV: 72.16 (-1.24)

Brunswick Billiards Goes Pink to Benefit Breast, Ovarian Health Education
PR Newswire - Tue Oct 07, 7:00AM CDT
By adding a splash of pink to your game room, you can help educate young women across the country about breast and ovarian cancer prevention and empower them to take charge of their health.
BC: 48.55 (+1.03)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Precious Metals and Energy Investors' Strategies

Updated Category News Views 143

Current Trends in Precious Metals The appeal of precious metals like gold and silver continues to gather momentum, particularly in light of recent global events. Many analysts believe that geopolitical tensions have created a catalyst for increased interest in gold as a safe haven. As governments grapple with economic challenges, investors are keenly observing changes in...

Continue Reading
Understanding P/E Ratios in the Context of Casey's General Stores

Updated Category News Views 175

Analyzing P/E Ratios for Investment Decisions In today’s market, understanding the performance metrics of stocks is vital. Currently, Casey's General Stores Inc. (NASDAQ: CASY) is noted at an impressive share price of $536.66. This reflects a modest increase of 0.33%. In examining market trends, the past month saw a slight decline of 4.39% in share value. However,...

Continue Reading
China's New Lending Outlook: Economic Recovery Strategies

Updated Category News Views 135

China's Recent New Lending Trends Recent updates reveal a significant rise in new bank lending in China. However, it didn't quite meet expectations, as analysts had hoped for a stronger performance. After disappointing figures in July, which hit a 15-year low, new data shows that Chinese banks issued around 900 billion yuan (approximately $126.86 billion) in new loans in...

Continue Reading
ParkOhio Shares Important Quarterly Dividend News for Investors

Updated Category News Views 177

ParkOhio Holdings Announces Latest Dividend Declaration Park-Ohio Holdings Corp. (NASDAQ: PKOH) recently declared a significant quarterly cash dividend of $0.125 per share to its common stockholders. This distribution demonstrates the company's ongoing commitment to providing returns to its shareholders. This dividend will be payable soon, marking another positive...

Continue Reading
Investigation Launched for Tourmaline Bio's Shareholders

Updated Category News Views 259

Investigation Overview on Tourmaline Bio, Inc. Recently, Monteverde & Associates PC, a renowned law firm, has initiated an investigation concerning Tourmaline Bio, Inc. (NASDAQ: TRML) and its proposed sale to Novartis AG. This potential acquisition raises several questions about the fairness of the deal, specifically regarding the cash payment offered to shareholders....

Continue Reading